A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Clinical trial NCT07187973 · RECRUITING

Trial details

NCT number: NCT07187973
Sponsor: Disc Medicine, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2026-01-06
Primary completion: 2027-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.